Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia | MicrobiomeTrials← Back to trialsNCT06931912
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-12-01Est. Completion: 2026-10-31
Enrollment target: 385 participants Locations- Regenerative Medicine Center and Red Blood Cell Disorders Center, Tianjin, Tianjin Municipality, China
Other microbiome trials you might be interested in
Sickle Cell Disease
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibro…
Los Angeles, United StatesEst. completion Dec 2026
Transfusion-dependent Beta-Thalassemia
This is a prospective, dual-centre, single dose, Phase IIb, single arm, open label study. The proposed clinical trial in…
Rome, ItalyEst. completion Oct 2028